Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study

Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study

Da Peng,1 Dongfeng Shan,2 Chengcheng Dai,1 Jie Li,3 Zifan Wang,1 Ziyi Huang,1 Rui Peng,1 Peng Zhao,4 Xuezhen Ma1 1Department of Oncology, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, Shandong, People’s Republic of China; 2The Affiliated Hospital of Qingdao University,...

Full description

Bibliographic Details
Main Authors: Peng D, Shan D, Dai C, Li J, Wang Z, Huang Z, Peng R, Zhao P, Ma X
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Cancer Management and Research
Subjects:
osimertinib
egfr-activating mutations
t790m egfr mutation
tyrosine-kinase inhibitors
non-small cell lung cancer;
Online Access:https://www.dovepress.com/real-world-data-on-osimertinib-in-chinese-patients-with-pretreated-egf-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/real-world-data-on-osimertinib-in-chinese-patients-with-pretreated-egf-peer-reviewed-article-CMAR

Similar Items